Silence Therapeutics Plc Adr (SLN)

Jun 26, 2026

Silence Therapeutics (SLN) surges 26.0%: Is this an indication of further gains? - MSN

Jun 26, 2026

Jun 26, 2026

Silence Therapeutics PLC Sponsored ADR Actuals & Estimates (NASDAQ:SLN) - TradingView

Jun 26, 2026

Jun 25, 2026

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance Singapore

Jun 25, 2026

Jun 25, 2026

Why is Silence Therapeutics stock surging today? - Investing.com

Jun 25, 2026

Jun 24, 2026

Silence Therapeutics stock jumps on Cantor Fitzgerald upgrade - Investing.com

Jun 24, 2026

Jun 23, 2026

Form 8K Silence Therapeutics plc For: 23 June By Investing.com - Investing.com Australia

Jun 23, 2026

Jun 17, 2026

H.C. Wainwright reiterates Silence Therapeutics stock rating at buy By Investing.com - Investing.com India

Jun 17, 2026

Jun 17, 2026

H.C. Wainwright reiterates Silence Therapeutics stock rating at buy - Investing.com

Jun 17, 2026

Jun 13, 2026

Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data - Sahm

Jun 13, 2026

Jun 11, 2026

Silence Therapeutics presents divesiran trial data at EHA By Investing.com - Investing.com South Africa

Jun 11, 2026

Jun 11, 2026

Silence Therapeutics presents divesiran trial data at EHA - Investing.com

Jun 11, 2026

May 31, 2026

Silence Therapeutics (SLN) soars 19.0%: Is further upside left in the stock? - MSN

May 31, 2026

May 26, 2026

SLNSilence Therapeutics Plc ADR Stock Price and Quote - Finviz

May 26, 2026

May 18, 2026

Silence Therapeutics (NASDAQ: SLN) registers $300M shelf, $100M ADSs included - Stock Titan

May 18, 2026

May 12, 2026

Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference - ChartMill

May 12, 2026

May 04, 2026

Revenue per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView

May 04, 2026

May 03, 2026

Book value per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView

May 03, 2026

May 01, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Short Interest Up 13.3% in April - MarketBeat

May 01, 2026

Apr 28, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 28, 2026

Apr 25, 2026

Silence Therapeutics (NASDAQ:SLN) Shares Down 1.8%Here's What Happened - MarketBeat

Apr 25, 2026

Apr 23, 2026

Wall Street Analysts Think Silence Therapeutics (SLN) Could Surge 556.19%: Read This Before Placing a Bet - MSN

Apr 23, 2026

Apr 22, 2026

Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight - GlobeNewswire Inc.

Apr 22, 2026

Apr 16, 2026

Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Apr 16, 2026

Apr 03, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com

Apr 03, 2026

Apr 03, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Apr 03, 2026

Mar 16, 2026

Why Urgent.ly Shares Are Trading Higher By Around 159%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 16, 2026

Mar 16, 2026

What is HC Wainwright's Estimate for SLN FY2030 Earnings? - MarketBeat

Mar 16, 2026

Mar 16, 2026

What is HC Wainwright’s Estimate for SLN FY2030 Earnings? - Defense World

Mar 16, 2026

Mar 09, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Mar 09, 2026

Mar 06, 2026

Silence Therapeutics Q4 Earnings Assessment - Sahm

Mar 06, 2026

Mar 05, 2026

Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High? - Yahoo Finance

Mar 05, 2026

Mar 04, 2026

Wall Street experts predict a potential 467.47% increase for Silence Therapeutics (SLN): Is such a surge in the stock truly possible? - Bitget

Mar 04, 2026

Feb 15, 2026

Analysts Set Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Price Target at $32.60 - Defense World

Feb 15, 2026

Feb 12, 2026

Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Feb 12, 2026

Feb 10, 2026

Silence Therapeutics (NASDAQ:SLN) Shares Down 5.1%Here's What Happened - MarketBeat

Feb 10, 2026

Feb 05, 2026

Revenues Working Against Silence Therapeutics plc's (NASDAQ:SLN) Share Price Following 27% Dive - Sahm

Feb 05, 2026